Skip to main content

Table 1 Response of the transfected human HIV-1-CAT and control plasmids in ex vivo T cells and control cell lines

From: A Repression-derepression Mechanism Regulating the Transcription of Human Immunodeficiency Virus Type 1 In Primary T Cells

DNA Clone

Cell Type

Stimulus

CAT Activity (% acetylation)

Inducibility

No. of Expts.

CMV-CAT

Jurkat

CM

78.1 (±9.6)

 

3

(transfection control)

 

PHA/PMA

90.1 (85.0/95.2)

× 1.15

2

U937

CM

30.7 (±13.0)

 

4

  

PHA/PMA

56.2 (±8.5)

× 1.83

3

 

PB T cells

CM

6.2 (5.5/7.0)

 

2

  

PHA/PMA

6.8 (5.6/8.0)

× 1.10

2

IL-2-CAT

Jurkat

CM

0.6 (±0.4)

 

3

(T-cell-specific control)

 

PHA/PMA

43.0 (±5.9)

× 71.67

3

U937

CM

0.6 (0.9/0.3)

 

2

  

PHA/PMA

0.6 (0.8/0.4)

× 1.00

2

 

PB T cells

CM

0.1 (0.0−0.2)

 

3

  

PHA/PMA

3.9 (±1.1)

× 39.00

3

pUC-BENN-CAT

Jurkat

CM

6.3 (±3.7)

 

4

(HIV-1 LTR)

 

PHA/PMA

16.9 (±6.7)

× 2.68

4

 

U937

CM

0.8 (±0.4)

 

3

  

PHA/PMA

0.7 (±0.5)

× 0.87

3

 

PB T cells

CM

0.7 (±0.2)

 

4

  

PHA/PMA

3.7 (±0.9)

× 5.29

3

5X RATS-CAT

Jurkat

CM

0*

 

3

  

PHA/PMA

0*

—

3

 

U937

CM

0*

 

3

  

PHA/PMA

0*

—

3

 

PB T cells

CM

0.4 (±0.2)

 

7

  

PHA/PMA

5.1 (±1.8)

× 12.75

5

  1. PB, peripheral blood; CM, control medium; 0*, nondetectable CAT activity; (± SEM); PHA/PMA, phytohaemoglutinine (5µg/ml)/phorbol myristate acetate (10 ng/ml).